High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells

Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, Vera Klemm, Annett Howe, Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Alberto Ospina Stella, Romain Rouet, Peter Schofield, Megan L. Faulks, Hannah Law, Thidarat Danwilai, Mitchell Starr, C. Mee Ling Munier, Daniel Christ, Mandeep Singh, Peter I Croucher, Fabienne Brilot-Turville, Stuart Turville, Tri Giang Phan, Gregory J Dore, David Darley, Philip Cunningham, Gail V Matthews, Anthony D Kelleher, John J Zaunders
doi: https://doi.org/10.1101/2022.07.22.22277947

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted July 24, 2022.
Download PDF
Data/Code
Email
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, Vera Klemm, Annett Howe, Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Alberto Ospina Stella, Romain Rouet, Peter Schofield, Megan L. Faulks, Hannah Law, Thidarat Danwilai, Mitchell Starr, C. Mee Ling Munier, Daniel Christ, Mandeep Singh, Peter I Croucher, Fabienne Brilot-Turville, Stuart Turville, Tri Giang Phan, Gregory J Dore, David Darley, Philip Cunningham, Gail V Matthews, Anthony D Kelleher, John J Zaunders
medRxiv 2022.07.22.22277947; doi: https://doi.org/10.1101/2022.07.22.22277947
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area